Suppliers / Oman Pharmaceutical Products

Oman Pharmaceutical Products

Oman 396 employees 4 duplicate records merged Updated 9 July 2026

Oman Pharmaceutical Products is a finished-dose manufacturer based in Oman. It appears in 124 regulatory filings across 9 regulators, without an active US DMF or CEP on file. Its filings concentrate with EDE (AE), SFDA (Saudi Arabia) and JFDA (JO). Its GMP standing is certified by ANVISA (Brazil) and EAEU_EEC. Its most recent recorded inspection, by US FDA, closed on 25 January 2023 as VAI.

0
active US DMFs
0
valid CEPs
4
registered plants 1 with an FDA FEI number
124
filings across 9 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
3 of 3 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 25 January 2023 VAI US FDA
  • 8 February 2020 VAI US FDA
  • 24 March 2016 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Salalah, United Arab Emirates Not on file
Salalah, United Arab Emirates Not on file
SALALAH, Oman Not on file
Oman, Oman 3005083824

Filings and GMP by regulator

Regulator Filings GMP certificates
EDE (AE) 53 None
SFDA (Saudi Arabia) 46 None
JFDA (JO) 8 None
TMDA (TZ) 5 None
MINSA (CR) 4 None
ZAMRA (ZM) 4 None
ANVISA (Brazil) None 1
EAEU_EEC None 1

Comparing suppliers?

Choose your molecules and target markets. Oman Pharmaceutical Products comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 25 January 2023.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates